Estimating SARS-CoV-2 infections and associated changes in COVID-19 severity and fatality

被引:16
|
作者
Marziano, Valentina [1 ]
Guzzetta, Giorgio [1 ]
Menegale, Francesco [1 ,2 ]
Sacco, Chiara [3 ]
Petrone, Daniele [3 ]
Mateo Urdiales, Alberto [3 ]
Del Manso, Martina [3 ]
Bella, Antonino [3 ]
Fabiani, Massimo [3 ]
Vescio, Maria Fenicia [3 ]
Riccardo, Flavia [3 ]
Poletti, Piero
Manica, Mattia
Zardini, Agnese
d'Andrea, Valeria [1 ]
Trentini, Filippo [1 ,4 ,5 ]
Stefanelli, Paola [3 ]
Rezza, Giovanni [6 ]
Palamara, Anna Teresa [3 ]
Brusaferro, Silvio [3 ]
Ajelli, Marco [7 ]
Pezzotti, Patrizio [3 ]
Merler, Stefano [1 ]
机构
[1] Bruno Kessler Fdn, Ctr Hlth Emergencies, Trento, Italy
[2] Univ Trento, Dept Math, Trento, Italy
[3] Ist Super San, Dept Infect Dis, Rome, Italy
[4] Bocconi Univ, Dondena Ctr Res Social Dynam & Publ Policy, Milan, Italy
[5] Bocconi Univ, COVID Crisis Lab, Milan, Italy
[6] Minist Hlth, Hlth Prevent directorate, Rome, Italy
[7] Indiana Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Lab Computat Epidemiol & Publ Hlth, Bloomington, IN USA
基金
欧盟地平线“2020”;
关键词
IFR; IHR; infection ascertainment ratio; infection fatality ratio; infection hospitalization ratio; SARS-CoV-2;
D O I
10.1111/irv.13181
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
BackgroundThe difficulty in identifying SARS-CoV-2 infections has not only been the major obstacle to control the COVID-19 pandemic but also to quantify changes in the proportion of infections resulting in hospitalization, intensive care unit (ICU) admission, or death. MethodsWe developed a model of SARS-CoV-2 transmission and vaccination informed by official estimates of the time-varying reproduction number to estimate infections that occurred in Italy between February 2020 and 2022. Model outcomes were compared with the Italian National surveillance data to estimate changes in the SARS-CoV-2 infection ascertainment ratio (IAR), infection hospitalization ratio (IHR), infection ICU ratio (IIR), and infection fatality ratio (IFR) in five different sub-periods associated with the dominance of the ancestral lineages and Alpha, Delta, and Omicron BA.1 variants. ResultsWe estimate that, over the first 2 years of pandemic, the IAR ranged between 15% and 40% (range of 95%CI: 11%-61%), with a peak value in the second half of 2020. The IHR, IIR, and IFR consistently decreased throughout the pandemic with 22-44-fold reductions between the initial phase and the Omicron period. At the end of the study period, we estimate an IHR of 0.24% (95%CI: 0.17-0.36), IIR of 0.015% (95%CI: 0.011-0.023), and IFR of 0.05% (95%CI: 0.04-0.08). ConclusionsSince 2021, changes in the dominant SARS-CoV-2 variant, vaccination rollout, and the shift of infection to younger ages have reduced SARS-CoV-2 infection ascertainment. The same factors, combined with the improvement of patient management and care, contributed to a massive reduction in the severity and fatality of COVID-19.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] The interplay of co-infections in shaping COVID-19 severity: Expanding the scope beyond SARS-CoV-2
    Baral, Budhadev
    Saini, Vaishali
    Kandpal, Meenakshi
    Kundu, Pratik
    Dixit, Amit Kumar
    Parmar, Hamendra Singh
    Meena, Ajay Kumar
    Trivedi, Pankaj
    Jha, Hem Chandra
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2024, 17 (08)
  • [42] ACE2 role in SARS-CoV-2 infectivity and Covid-19 severity
    Azizan, Elena
    Brown, Morris
    MALAYSIAN JOURNAL OF PATHOLOGY, 2020, 42 (03) : 363 - 367
  • [43] Human genetic factors associated with susceptibility to SARS-CoV-2 infection and COVID-19 disease severity
    Anastassopoulou, Cleo
    Gkizarioti, Zoi
    Patrinos, George P.
    Tsakris, Athanasios
    HUMAN GENOMICS, 2020, 14 (01)
  • [44] Is SARS-CoV-2 associated with liver dysfunction in COVID-19 patients?
    Ali, Nurshad
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2020, 44 (04) : E84 - E86
  • [45] COVID-19 vaccines efficacy in preventing or limiting SARS-CoV-2 infections
    Mattiuzzi, Camilla
    Lippi, Giuseppe
    JOURNAL OF INFECTION, 2022, 84 (05) : 726 - 727
  • [46] COVID-19 signalome: Pathways for SARS-CoV-2 infection and impact on COVID-19 associated comorbidity
    Lundstrom, Kenneth
    Hromic-Jahjefendic, Altijana
    Bilajac, Esma
    Aljabali, Alaa A. A.
    Baralic, Katarina
    Sabri, Nagwa A.
    Shehata, Eslam M.
    Raslan, Mohamed
    Ferreira, Ana Claudia B. H.
    Orlandi, Lidiane
    Serrano-Aroca, Angel
    Tambuwala, Murtaza M.
    Uversky, Vladimir N.
    Azevedo, Vasco
    Alzahrani, Khalid J.
    Alsharifm, Khalaf F.
    Halawani, Ibrahim F.
    Alzahrani, Fuad M.
    Redwan, Elrashdy M.
    Barhl, Debmalya
    CELLULAR SIGNALLING, 2023, 101
  • [47] SARS-CoV-2/COVID-19-Auswirkungen auf die PlazentaImpact of SARS-CoV-2/COVID-19 on the placenta
    T. Menter
    A. Tzankov
    E. Bruder
    Der Pathologe, 2021, 42 (6): : 591 - 597
  • [48] Estimating disease severity of Omicron and Delta SARS-CoV-2 infections COMMENT
    Sigal, Alex
    Milo, Ron
    Jassat, Waasila
    NATURE REVIEWS IMMUNOLOGY, 2022, 22 (05) : 267 - 269
  • [49] African Genetic Representation in the Context of SARS-CoV-2 Infection and COVID-19 Severity
    Petersen, Desiree C.
    Steyl, Chrystal
    Scholtz, Denise
    Baker, Bienyameen
    Abdullah, Ibtisam
    Uren, Caitlin
    Moeller, Marlo
    Host Genet Project
    FRONTIERS IN GENETICS, 2022, 13
  • [50] Estimating immunity with mathematical models for SARS-CoV-2 after COVID-19 vaccination
    Yoshifumi Uwamino
    Kengo Nagashima
    Ayumi Yoshifuji
    Shigeru Suga
    Mizuho Nagao
    Takao Fujisawa
    Munekazu Ryuzaki
    Yoshiaki Takemoto
    Ho Namkoong
    Masatoshi Wakui
    Hiromichi Matsushita
    Naoki Hasegawa
    Yasunori Sato
    Mitsuru Murata
    npj Vaccines, 8